AI in pharmaceutical industry is revolutionizing drug discovery. GSK's $300M partnership with Relation Therapeutics accelerates treatments for osteoarthritis and fibrosis.
Johnson & Johnson's acquisition of Intra-Cellular Therapies enhances its neuroscience portfolio with CAPLYTA® and a robust pipeline, addressing critical mental health needs.
Understand the importance of patent analysis in biotech investments to mitigate risks, secure market exclusivity, and identify innovation opportunities in 2025.